People channel feed

FDA shakes up top lead­er­ship around gener­ic drugs

Last year
FDA+

Al­ca­mi ap­points new CEO as for­mer chief Patrick Walsh an­nounces re­tire­ment

Last year
Manufacturing

Who pays the most (and least) in bio­phar­ma? We crunched me­di­an salary da­ta from 175 com­pa­nies

Last year

CBER's Pe­ter Marks shares pan­dem­ic lessons as FDA con­tin­ues 'go­ing through the back­log'

Last year
Pharma
FDA+

Ex­clu­sive: GSK CEO Em­ma Walm­s­ley talks about vac­cines, M&A and the com­pa­ny’s fu­ture

Last year

Bio­phar­ma lead­ers paving the way for LGBTQ+ sci­en­tists, pa­tients, en­tre­pre­neurs and C-suites

Last year
Special

Es­cap­ing an im­prob­a­ble up­bring­ing, Greg Ver­dine places his biggest ca­reer bets in drug­ging the ‘un­drug­gable’

Last year
In Focus

Il­lu­mi­na names Ho­log­ic CEO as new board mem­ber and chair

Last year
Pharma

Catal­ent makes ad­di­tion­al lay­offs at In­di­ana fa­cil­i­ty

Last year
Manufacturing

On­corus lays off most of its re­main­ing team, warns of wind-down as it takes one last shot at deal­mak­ing

Last year

San­doz plans to stay lo­cal af­ter No­var­tis sep­a­ra­tion, se­lect­ing new HQ in Basel

Last year
Pharma

Bausch + Lomb to pro­mote three SVPs to ex­ec­u­tive team

Last year

Far­al­lon says it's won all de­sired board seats from Ex­elix­is af­ter share­hold­er vote

Last year

RA Cap­i­tal-backed non-vi­ral gene ther­a­py start­up Sum­ma­tion Bio to shut down

2 years ago
Cell/Gene Tx

Af­ter PhI­II let­down, Rain On­col­o­gy lays off 65% of staff, al­ters clin­i­cal plans for sole as­set

3 years ago
R&D

Atea's board re­jects un­so­licit­ed cash of­fer from Tang Cap­i­tal's Con­cen­tra

3 years ago
Deals

On­copep­tides says Swedish au­thor­i­ties end­ed probe in­to CSO Jakob Lind­berg over al­leged in­sid­er in­for­ma­tion shar­ing

3 years ago
Law

Il­lu­mi­na chair­man oust­ed from board as ac­tivist in­vestor Ic­ahn wins par­tial vic­to­ry

3 years ago

Bio­phar­ma's 20 high­est-paid CEOs of 2022, each bring­ing in $20M+ pay­days

3 years ago

Benev­o­len­tAI lays off around 180 staffers, cuts pipeline pro­grams in re­org

3 years ago

With Mod­er­na wind­fall, Har­vard pro­fes­sor and in­te­grins leg­end Tim Springer do­nates $210M to his In­sti­tute for Pro­tein In­no­va­tion

3 years ago
Financing

Di­ag­nos­tics out­fit lays off third of em­ploy­ees, now look­ing at 's­trate­gic al­ter­na­tives'

3 years ago
Diagnostics

Af­fimed lays off around 50 staffers as it brings com­bo NK cell ther­a­py to PhII

3 years ago
R&D

Ex­clu­sive: Cell and gene ther­a­py biotech cre­ator Re­play plucks Al­lo­gene CMO Arun Bal­aku­maran to lead clin­i­cal tri­als

3 years ago
Cell/Gene Tx
First page Previous page 25262728293031 Next page Last page
A service from the Financial Times